Table 2.
Number of mapped unique variables per cohort and modality
| Dataset | Demographics | Clinical | MRI | PET | CSF | Plasma | Comorbidities | Family | Lifestyle |
|---|---|---|---|---|---|---|---|---|---|
| A4 | 13 | 5 | 44 | 1 | 0 | 0 | 2 | 6 | 4 |
| ABVIB | 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| ADNI | 17 | 23 | 247 | 3 | 10 | 11 | 14 | 8 | 5 |
| AIBL | 15 | 16 | 3 | 2 | 3 | 0 | 12 | 2 | 5 |
| ANMerge | 14 | 11 | 136 | 0 | 0 | 0 | 1 | 3 | 1 |
| ARWIBO | 21 | 14 | 1026 | 21 | 3 | 6 | 13 | 3 | 2 |
| DOD-ADNI | 21 | 20 | 249 | 1 | 3 | 0 | 18 | 6 | 6 |
| EDSD | 12 | 8 | 1026 | 8 | 3 | 2 | 4 | 2 | 0 |
| EMIF-1000 | 8 | 4 | 3 | 1 | 6 | 0 | 3 | 0 | 4 |
| EPAD V.IMI | 14 | 11 | 80 | 0 | 3 | 0 | 17 | 5 | 4 |
| I-ADNI | 15 | 10 | 1026 | 8 | 3 | 1 | 1 | 2 | 0 |
| JADNI | 15 | 21 | 871 | 2 | 3 | 0 | 14 | 6 | 4 |
| NACC | 20 | 17 | 123 | 2 | 3 | 0 | 14 | 3 | 6 |
| OASIS | 16 | 3 | 1026 | 8 | 3 | 2 | 0 | 2 | 0 |
| PREVENT-AD | 15 | 4 | 0 | 0 | 7 | 0 | 5 | 5 | 0 |
| PharmaCog | 13 | 16 | 1026 | 8 | 3 | 2 | 0 | 2 | 0 |
| ROSMAP | 12 | 9 | 0 | 0 | 0 | 0 | 8 | 0 | 1 |
| VASCULAR | 9 | 8 | 31 | 0 | 0 | 0 | 3 | 0 | 2 |
| VITA | 12 | 3 | 1026 | 8 | 3 | 2 | 0 | 2 | 0 |
| WMH-AD | 12 | 4 | 1025 | 8 | 3 | 2 | 0 | 2 | 0 |
| Total unique terms | 23 | 34 | 1050 | 24 | 14 | 15 | 20 | 9 | 7 |